KeriFlex silicone finger joint implant, front view

Hand & Wrist · MCP and PIP Arthroplasty

KeriFlex® Silicone Finger Joint Implants

Flexible one-piece silicone-elastomer hinged implants for MCP and PIP finger-joint arthroplasty. Validated to 10 million flex cycles across a 0° to 90° range. 13 sizes (7 MCP, 6 PIP) match patient anatomy. Manufactured by KeriMedical in Geneva.

Manufactured by KeriMedical SA (Geneva, Switzerland) · Distributed in Cyprus by OrganoGEN Limited

13Implant sizes
(7 MCP + 6 PIP)
10MFlex cycles validated
(0° to 90° range)
15° / 30°Resting angulation
(PIP / MCP, hand-at-rest)
EU + USACE 1250 + FDA 510(k)
(K211385)
verifiedGESY-Coveredscience10M-Cycle TestedpublicCE-Marked + FDA-Clearedsupport_agentSurgical Support

In One Paragraph

KeriFlex® is a family of flexible, one-piece, hinged silicone-elastomer implants for metacarpophalangeal (MCP) and proximal interphalangeal (PIP) finger-joint arthroplasty, manufactured by KeriMedical in Geneva. The implant family covers 13 sizes (7 MCP, 6 PIP) so the surgeon matches anatomy to a one-piece hinge with a resting angulation of 30° at the MCP and 15° at the PIP that mimics the natural posture of the hand at rest. Implants are validated to 10 million flex cycles in vitro across a 0° to 90° range. CE-marked under EU MDR 2017/745 (notified body 1250) and FDA 510(k) cleared in the United States (K211385, 27 July 2022). Sold sterile, single-use, non-absorbable. GESY-covered in Cyprus through OrganoGEN.

Overview

KeriFlex® is a family of flexible, one-piece, hinged silicone-elastomer implants used for cementless replacement of the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) finger joints. The construct restores pain-free range of motion in fingers affected by rheumatoid, degenerative or post-traumatic arthritis where conservative care has failed.

KeriMedical, the Swiss manufacturer, supplies KeriFlex® in 13 sizes: 7 MCP (sizes 00 to 60) and 6 PIP (sizes 0 to 5). Each implant is a single-piece silicone elastomer hinge with the proximal and distal stems set at an angle that mimics the natural posture of the hand at rest: 30° at the MCP joint and 15° at the PIP joint. The geometry respects the anatomic centre of rotation, limits conflict with the extensor mechanism, and tolerates the natural compressive stress of the joint.

Bench testing validates KeriFlex® to 10 million flex cycles across a 0° to 90° flexion-extension range. The implants are single-use, non-absorbable, and supplied sterile. The dedicated ancillary set uses progressive proximal and distal rasps, a bone awl, a starter and a conical drill, and is validated for steam sterilisation at 134°C / 18 min and 134°C / 3 min per ANSI/AAMI ST79 and EN ISO 17665.

KeriFlex® is CE-marked under EU MDR 2017/745 (notified body 1250) and FDA 510(k) cleared in the United States as the *KeriFlex® MCP and PIP Finger Joint Prostheses* (K211385, decision date 27 July 2022). It sits within the silicone MCP and PIP arthroplasty class, which has the most mature long-term evidence base of any finger-joint replacement technology.

OrganoGEN is the Cyprus distributor and provides surgical support at every implantation. KeriFlex® is GESY-covered when implanted by a participating hand surgeon at a GESY-contracted hospital.

Indications & Contraindications

check_circleIndicated For

  • Rheumatoid arthritis of the MCP or PIP joints with painful deformity
  • Primary (degenerative) osteoarthritis of the MCP or PIP joints
  • Post-traumatic finger-joint arthritis
  • Failed conservative management with persistent pain, stiffness or fixed deformity

blockContraindicated For

  • Active local or systemic infection
  • Bone quality judged inadequate by the surgeon
  • Severely compromised soft-tissue envelope (skin, extensor mechanism, collateral ligaments)
  • Skeletal immaturity (children, adolescents)
  • Pregnancy or breast-feeding

Technical Specifications

ManufacturerKeriMedical SA, Geneva, Switzerland
MaterialSilicone elastomer (one-piece, flexible, hinged construct)
Available sizes13 total. 7 MCP (sizes 00, 10, 20, 30, 40, 50, 60). 6 PIP (sizes 0, 1, 2, 3, 4, 5)
Resting angulation30° at MCP, 15° at PIP (mimics hand-at-rest posture)
Flexion / extension range0° to 90°
In-vitro durability10 million flex cycles validated
PackagingSingle-use, non-absorbable, sterile
Instrumentation sterilisationValidated at 134°C / 18 min and 134°C / 3 min per ANSI/AAMI ST79 and EN ISO 17665
Regulatory (EU)CE-marked, EU MDR 2017/745, notified body 1250
Regulatory (US)FDA 510(k) cleared, K211385, decision date 27 July 2022
Distribution in CyprusOrganoGEN Limited
GESY reimbursementApproved (active ZC code)

Clinical evidence

Morrell & Weiss 2018 (silicone MCP arthroplasty class)

Longest published series in primary MCP osteoarthritis. 35 patients, mean 8.3-year follow-up (range 2 to 17 years), 97% clinical implant survivorship, mean pain VAS 0.3 of 10 at final review, mean final active flexion arc 4° to 73°.

J Hand Surg Am 2018, PubMed 29146506
KeriMedical bench-test programme

KeriFlex® implants validated to 10 million flex cycles in vitro across a 0° to 90° flexion-extension range.

Manufacturer documentation
FDA 510(k) K211385

Substantial-equivalence clearance for the KeriFlex® MCP and PIP Finger Joint Prostheses, decision date 27 July 2022.

accessdata.fda.gov

GESY Coverage & Pricing in Cyprus

The KeriFlex® finger implant is GESY-covered when implanted by a participating hand surgeon at a GESY-contracted hospital. The implant cost is included in the hospital reimbursement, and patients are not billed separately for the device.

For self-pay or international patients, OrganoGEN provides hospital quotations on request. Request a quote with your hospital's procurement details.

Frequently asked questions

Which finger joints can KeriFlex® replace?
Both the metacarpophalangeal (MCP) joints at the base of the fingers and the proximal interphalangeal (PIP) joints in the middle of the fingers. Thirteen implant sizes are available: 7 MCP (sizes 00 to 60) and 6 PIP (sizes 0 to 5).
What is KeriFlex® made of?
Silicone elastomer, formed as a flexible one-piece hinge. The proximal and distal stems sit at an angle that mimics the natural posture of the hand at rest: 30° at the MCP joint, 15° at the PIP joint.
Is KeriFlex® CE-marked and FDA-cleared?
Yes. KeriFlex® is CE-marked under EU MDR 2017/745 (notified body 1250). It is also FDA 510(k) cleared in the United States under K211385, with a decision date of 27 July 2022.
What is the durability of the implant?
Bench testing validates KeriFlex® to 10 million flex cycles in vitro across the 0° to 90° range. The broader silicone MCP and PIP arthroplasty class has the most mature long-term evidence base in finger-joint replacement, with the longest primary-osteoarthritis silicone MCP series reporting 97% clinical implant survivorship at a mean 8.3-year follow-up and mean pain VAS of 0.3 of 10 at final review (Morrell & Weiss 2018, PubMed 29146506).
Is KeriFlex® covered by GESY in Cyprus?
Yes. KeriFlex® is GESY-covered for MCP and PIP arthroplasty when implanted by a participating hand surgeon at a GESY-contracted hospital.
Who manufactures KeriFlex®?
KeriMedical SA in Geneva, Switzerland. KeriMedical is dedicated exclusively to hand and wrist implants and also manufactures the Touch® CMC Prosthesis and the KeriFuse® arthrodesis implant. OrganoGEN is the Cyprus distributor.
What does recovery look like after KeriFlex® arthroplasty?
Protected active flexion and extension exercises start within a few days of surgery, with the operated hand protected from deviating forces (a removable splint is typical). The detailed rehabilitation protocol is led by the operating surgeon and a hand therapist, and adapts to whether the underlying diagnosis is rheumatoid arthritis (often staged across multiple joints) or primary or post-traumatic osteoarthritis.

More in Hand & Wrist

Other products OrganoGEN distributes in the Hand & Wrist category.

arrow_back
KeriFlex® Finger Implant
Hand & Wrist · MCP and PIP Arthroplasty

KeriFlex® Silicone Finger Joint Implants

Flexible one-piece silicone-elastomer hinged implants for MCP and PIP finger-joint arthroplasty. Validated to 10 million flex cycles across a 0° to 90° range. 13 sizes (7 MCP, 6 PIP) match patient anatomy. Manufactured by KeriMedical in Geneva.

verifiedGESY-Coveredscience10M-Cycle TestedpublicCE-Marked + FDA-Clearedsupport_agentSurgical Support
KeriFlex silicone finger joint implant, front view
KeriFlex implant seated at the finger joint
KeriFlex implant at the finger joint, lateral view
KeriFlex implant tray with CE marking
KeriFlex instrument tray with colour-coded sizers

In One Paragraph

KeriFlex® is a family of flexible, one-piece, hinged silicone-elastomer implants for metacarpophalangeal (MCP) and proximal interphalangeal (PIP) finger-joint arthroplasty, manufactured by KeriMedical in Geneva. The implant family covers 13 sizes (7 MCP, 6 PIP) so the surgeon matches anatomy to a one-piece hinge with a resting angulation of 30° at the MCP and 15° at the PIP that mimics the natural posture of the hand at rest. Implants are validated to 10 million flex cycles in vitro across a 0° to 90° range. CE-marked under EU MDR 2017/745 (notified body 1250) and FDA 510(k) cleared in the United States (K211385, 27 July 2022). Sold sterile, single-use, non-absorbable. GESY-covered in Cyprus through OrganoGEN.

Overview

Overview

KeriFlex® is a family of flexible, one-piece, hinged silicone-elastomer implants used for cementless replacement of the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) finger joints. The construct restores pain-free range of motion in fingers affected by rheumatoid, degenerative or post-traumatic arthritis where conservative care has failed.

KeriMedical, the Swiss manufacturer, supplies KeriFlex® in 13 sizes: 7 MCP (sizes 00 to 60) and 6 PIP (sizes 0 to 5). Each implant is a single-piece silicone elastomer hinge with the proximal and distal stems set at an angle that mimics the natural posture of the hand at rest: 30° at the MCP joint and 15° at the PIP joint. The geometry respects the anatomic centre of rotation, limits conflict with the extensor mechanism, and tolerates the natural compressive stress of the joint.

Clinical Use

Indications & Contraindications

check_circleIndicated for

  • Rheumatoid arthritis of the MCP or PIP joints with painful deformity
  • Primary (degenerative) osteoarthritis of the MCP or PIP joints
  • Post-traumatic finger-joint arthritis
  • Failed conservative management with persistent pain, stiffness or fixed deformity

cancelContraindicated

  • Active local or systemic infection
  • Bone quality judged inadequate by the surgeon
  • Severely compromised soft-tissue envelope (skin, extensor mechanism, collateral ligaments)
  • Skeletal immaturity (children, adolescents)
  • Pregnancy or breast-feeding
Technical

Technical Specifications

Manufacturer
KeriMedical SA, Geneva, Switzerland
Material
Silicone elastomer (one-piece, flexible, hinged construct)
Available sizes
13 total. 7 MCP (sizes 00, 10, 20, 30, 40, 50, 60). 6 PIP (sizes 0, 1, 2, 3, 4, 5)
Resting angulation
30° at MCP, 15° at PIP (mimics hand-at-rest posture)
Flexion / extension range
0° to 90°
In-vitro durability
10 million flex cycles validated
Packaging
Single-use, non-absorbable, sterile
Instrumentation sterilisation
Validated at 134°C / 18 min and 134°C / 3 min per ANSI/AAMI ST79 and EN ISO 17665
Regulatory (EU)
CE-marked, EU MDR 2017/745, notified body 1250
Regulatory (US)
FDA 510(k) cleared, K211385, decision date 27 July 2022
Distribution in Cyprus
OrganoGEN Limited
GESY reimbursement
Approved (active ZC code)
Evidence

Clinical evidence

Morrell & Weiss 2018 (silicone MCP arthroplasty class) Longest published series in primary MCP osteoarthritis. 35 patients, mean 8.3-year follow-up (range 2 to 17 years), 97% clinical implant survivorship, mean pain VAS 0.3 of 10 at final review, mean final active flexion arc 4° to 73°. J Hand Surg Am 2018, PubMed 29146506
KeriMedical bench-test programme KeriFlex® implants validated to 10 million flex cycles in vitro across a 0° to 90° flexion-extension range. Manufacturer documentation
FDA 510(k) K211385 Substantial-equivalence clearance for the KeriFlex® MCP and PIP Finger Joint Prostheses, decision date 27 July 2022. accessdata.fda.gov
GESY & Cost

GESY Coverage & Pricing in Cyprus

The KeriFlex® finger implant is GESY-covered when implanted by a participating hand surgeon at a GESY-contracted hospital. The implant cost is included in the hospital reimbursement, and patients are not billed separately for the device.

For self-pay or international patients, OrganoGEN provides hospital quotations on request. Request a quote with your hospital's procurement details.

FAQ

Frequently asked questions

Which finger joints can KeriFlex® replace?
Both the metacarpophalangeal (MCP) joints at the base of the fingers and the proximal interphalangeal (PIP) joints in the middle of the fingers. Thirteen implant sizes are available: 7 MCP (sizes 00 to 60) and 6 PIP (sizes 0 to 5).
What is KeriFlex® made of?
Silicone elastomer, formed as a flexible one-piece hinge. The proximal and distal stems sit at an angle that mimics the natural posture of the hand at rest: 30° at the MCP joint, 15° at the PIP joint.
Is KeriFlex® CE-marked and FDA-cleared?
Yes. KeriFlex® is CE-marked under EU MDR 2017/745 (notified body 1250). It is also FDA 510(k) cleared in the United States under K211385, with a decision date of 27 July 2022.
What is the durability of the implant?
Bench testing validates KeriFlex® to 10 million flex cycles in vitro across the 0° to 90° range. The broader silicone MCP and PIP arthroplasty class has the most mature long-term evidence base in finger-joint replacement, with the longest primary-osteoarthritis silicone MCP series reporting 97% clinical implant survivorship at a mean 8.3-year follow-up and mean pain VAS of 0.3 of 10 at final review (Morrell & Weiss 2018, PubMed 29146506).
Is KeriFlex® covered by GESY in Cyprus?
Yes. KeriFlex® is GESY-covered for MCP and PIP arthroplasty when implanted by a participating hand surgeon at a GESY-contracted hospital.
Who manufactures KeriFlex®?
KeriMedical SA in Geneva, Switzerland. KeriMedical is dedicated exclusively to hand and wrist implants and also manufactures the Touch® CMC Prosthesis and the KeriFuse® arthrodesis implant. OrganoGEN is the Cyprus distributor.
What does recovery look like after KeriFlex® arthroplasty?
Protected active flexion and extension exercises start within a few days of surgery, with the operated hand protected from deviating forces (a removable splint is typical). The detailed rehabilitation protocol is led by the operating surgeon and a hand therapist, and adapts to whether the underlying diagnosis is rheumatoid arthritis (often staged across multiple joints) or primary or post-traumatic osteoarthritis.
More in Hand & Wrist

Related products